首页 > 最新文献

Ethics, Medicine and Public Health最新文献

英文 中文
First Marburg virus outbreak in Rwanda: public health challenges, response strategies, and global implications 卢旺达首次爆发马尔堡病毒:公共卫生挑战、应对战略和全球影响
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.101018
O.J. Okesanya , S. Jamil , M.M. Ahmed , A.M. Adebayo , B.M. Ukoaka , S. Khandker , A. Gilbert
{"title":"First Marburg virus outbreak in Rwanda: public health challenges, response strategies, and global implications","authors":"O.J. Okesanya , S. Jamil , M.M. Ahmed , A.M. Adebayo , B.M. Ukoaka , S. Khandker , A. Gilbert","doi":"10.1016/j.jemep.2024.101018","DOIUrl":"10.1016/j.jemep.2024.101018","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 101018"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to Totalitarian Approaches to Risk and the Banality of Harm in Secure and Forensic Psychiatric Settings in England and Wales. Ethics, Medicine and Public Health 2022;23:100776, Sarah Markham, Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London PO72 De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom 英格兰和威尔士安全和法医精神病学环境中的风险极权主义方法和伤害的平庸性》撤稿通知。伦理、医学与公共卫生》2022;23:100776,萨拉-马卡姆(Sarah Markham),伦敦国王学院精神病学、心理学与神经科学研究所(IoPPN)生物统计学与健康信息学系,地址:PO72 De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom。
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.100993

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy).

This article has been retracted at the request of the Editor-in-Chief.

本文已被撤稿:请参阅爱思唯尔撤稿政策 (https://www.elsevier.com/locate/withdrawalpolicy)。应主编要求,本文已被撤稿。
{"title":"Retraction notice to Totalitarian Approaches to Risk and the Banality of Harm in Secure and Forensic Psychiatric Settings in England and Wales. Ethics, Medicine and Public Health 2022;23:100776, Sarah Markham, Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London PO72 De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom","authors":"","doi":"10.1016/j.jemep.2024.100993","DOIUrl":"https://doi.org/10.1016/j.jemep.2024.100993","url":null,"abstract":"<div><p>This article has been retracted: please see Elsevier Policy on Article Withdrawal (<span>https://www.elsevier.com/locate/withdrawalpolicy</span><svg><path></path></svg>).</p><p>This article has been retracted at the request of the Editor-in-Chief.</p></div>","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 100993"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352552524000288/pdfft?md5=2edb9727148feb9f5f6fbc9914301fa2&pid=1-s2.0-S2352552524000288-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141487262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global health to one health: Between interdisciplinarity and bioethics? 从全球健康到全民健康:在跨学科和生物伦理学之间?
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.101001
H.-C. Stoeklé , C. Hervé
{"title":"Global health to one health: Between interdisciplinarity and bioethics?","authors":"H.-C. Stoeklé ,&nbsp;C. Hervé","doi":"10.1016/j.jemep.2024.101001","DOIUrl":"10.1016/j.jemep.2024.101001","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 101001"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141998118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of consumption and expenditure of anti-VEFG drugs used in maculopathies between current events and future prospects 黄斑病变中使用的抗血管内皮生长因子药物的消费和支出现状与未来前景分析
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.101002
F. Ferrara , M. Capuozzo , R. Pasquinucci , A. Zovi , R. Langella , U. Trama , E. Nava , F. Primiano , G. Russo

Background

Macular diseases are becoming more prevalent among the elderly population, with several equally effective treatment options available, including biosimilar drugs which could offer significant cost savings.

Objective

This study aimed to highlight the rising expenses associated with purchasing anti-VEGF drugs due to an increasing number of patients and the introduction of new medications. Additionally, it seeks to encourage healthcare professionals to consider using biosimilar drugs more frequently.

Methodology

Data on patient numbers categorized by gender, the quantity of drug vials used and the corresponding expenditure on anti-VEGF medications for treating macular diseases have been collected and compared for the second half of 2022 and 2023 in an Italian healthcare institution.

Results/discussion

The study revealed a noticeable uptick in treatments and healthcare costs, with 767 patients treated and a total expenditure of €715,630.22 during the analyzed periods. This represented an increase of 99 patients, 185 injections, and €134,465.74 compared to the preceding period.

Conclusion/perspectives

Given the escalating expenses associated with macular disease therapy, it is imperative for central governments and regulatory administrations to intensify efforts to monitor pharmaceutical spending and establish guidelines promoting the adoption of biosimilar drugs. These alternatives offer comparable clinical efficacy while yielding substantial healthcare cost savings.

背景白内障在老年人群中越来越普遍,目前有多种同样有效的治疗方法,其中包括可显著节约成本的生物类似药。研究目的本研究旨在强调由于患者人数的增加和新药的推出,购买抗血管内皮生长因子药物的相关费用不断增加。方法收集了意大利一家医疗机构 2022 年下半年和 2023 年用于治疗黄斑疾病的抗血管内皮生长因子药物的患者人数(按性别分类)、药瓶使用量和相应支出数据,并进行了比较。结论/展望鉴于与黄斑病治疗相关的费用不断攀升,中央政府和监管部门必须加大力度监控医药支出,并制定促进采用生物类似药的指导方针。这些替代品具有可比的临床疗效,同时还能节省大量医疗成本。
{"title":"Analysis of consumption and expenditure of anti-VEFG drugs used in maculopathies between current events and future prospects","authors":"F. Ferrara ,&nbsp;M. Capuozzo ,&nbsp;R. Pasquinucci ,&nbsp;A. Zovi ,&nbsp;R. Langella ,&nbsp;U. Trama ,&nbsp;E. Nava ,&nbsp;F. Primiano ,&nbsp;G. Russo","doi":"10.1016/j.jemep.2024.101002","DOIUrl":"10.1016/j.jemep.2024.101002","url":null,"abstract":"<div><h3>Background</h3><p>Macular diseases are becoming more prevalent among the elderly population, with several equally effective treatment options available, including biosimilar drugs which could offer significant cost savings.</p></div><div><h3>Objective</h3><p>This study aimed to highlight the rising expenses associated with purchasing anti-VEGF drugs due to an increasing number of patients and the introduction of new medications. Additionally, it seeks to encourage healthcare professionals to consider using biosimilar drugs more frequently.</p></div><div><h3>Methodology</h3><p>Data on patient numbers categorized by gender, the quantity of drug vials used and the corresponding expenditure on anti-VEGF medications for treating macular diseases have been collected and compared for the second half of 2022 and 2023 in an Italian healthcare institution.</p></div><div><h3>Results/discussion</h3><p>The study revealed a noticeable uptick in treatments and healthcare costs, with 767 patients treated and a total expenditure of €715,630.22 during the analyzed periods. This represented an increase of 99 patients, 185 injections, and €134,465.74 compared to the preceding period.</p></div><div><h3>Conclusion/perspectives</h3><p>Given the escalating expenses associated with macular disease therapy, it is imperative for central governments and regulatory administrations to intensify efforts to monitor pharmaceutical spending and establish guidelines promoting the adoption of biosimilar drugs. These alternatives offer comparable clinical efficacy while yielding substantial healthcare cost savings.</p></div>","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 101002"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142041005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating traditional medicine requires proper risk assessment: The case of the Ivory Coast 整合传统医学需要适当的风险评估:象牙海岸的案例
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.101011
A.C. Guita , T. Daly
{"title":"Integrating traditional medicine requires proper risk assessment: The case of the Ivory Coast","authors":"A.C. Guita ,&nbsp;T. Daly","doi":"10.1016/j.jemep.2024.101011","DOIUrl":"10.1016/j.jemep.2024.101011","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 101011"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Politics and public health: Challenges for science in democracy 政治与公共卫生:民主中的科学所面临的挑战
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.101009
C. Bommier
{"title":"Politics and public health: Challenges for science in democracy","authors":"C. Bommier","doi":"10.1016/j.jemep.2024.101009","DOIUrl":"10.1016/j.jemep.2024.101009","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 101009"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How AI can revolutionize retroperitoneal sarcoma diagnosis: Is it finally time and more ethical to shift from scepticism to support? 人工智能如何彻底改变腹膜后肉瘤的诊断:从怀疑到支持,是否终于到了更合乎道德的时候?
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.100969
K. Evangelou
{"title":"How AI can revolutionize retroperitoneal sarcoma diagnosis: Is it finally time and more ethical to shift from scepticism to support?","authors":"K. Evangelou","doi":"10.1016/j.jemep.2024.100969","DOIUrl":"https://doi.org/10.1016/j.jemep.2024.100969","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 100969"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140052408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethics of surgically treating cleft lip for patients who lack legal authority to consent 对无法定同意权的患者进行唇裂手术治疗的伦理问题
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.100978
S. Sharma , B. Bala , J.M. Appel
{"title":"Ethics of surgically treating cleft lip for patients who lack legal authority to consent","authors":"S. Sharma ,&nbsp;B. Bala ,&nbsp;J.M. Appel","doi":"10.1016/j.jemep.2024.100978","DOIUrl":"https://doi.org/10.1016/j.jemep.2024.100978","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 100978"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140346840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Has Covid-19 changed our view of death? An example of medical anthropology in the Catacombs of Paris (France) 科维德-19 是否改变了我们对死亡的看法?法国巴黎地下墓穴中的医学人类学实例
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2024.100991
P. Charlier , S. Calle
{"title":"Has Covid-19 changed our view of death? An example of medical anthropology in the Catacombs of Paris (France)","authors":"P. Charlier ,&nbsp;S. Calle","doi":"10.1016/j.jemep.2024.100991","DOIUrl":"https://doi.org/10.1016/j.jemep.2024.100991","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 100991"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141068616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
End of life in France: Change the law or change mentalities? 法国的生命终结:改变法律还是改变心态?
Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.jemep.2023.100965
P. Charlier , C. Huriet
{"title":"End of life in France: Change the law or change mentalities?","authors":"P. Charlier ,&nbsp;C. Huriet","doi":"10.1016/j.jemep.2023.100965","DOIUrl":"https://doi.org/10.1016/j.jemep.2023.100965","url":null,"abstract":"","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"32 ","pages":"Article 100965"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139548588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ethics, Medicine and Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1